Myrna Luna-Gutiérrez

13PUBLICATIONS
21CO-AUTHORS
Radiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 30, 2025
Enhancing Cytosolic Internalization of [177Lu]Lu-iPSMA in Prostate Cancer Cells: The Effect of Conjugating a GRP78 Inhibitor to the Radiotherapeutic Molecule.

Erika Azorín-Vega, Daniel García-Arce, Myrna Luna-Gutiérrez

|Jul 30, 2025
Synthesis and Evaluation of [18F]AlF-NOTA-iPD-L1 as a Potential Theranostic Pair for [177Lu]Lu-DOTA-iPD-L1.

Guillermina Ferro-Flores, Myrna Luna-Gutiérrez, Blanca Ocampo-García

|Jul 29, 2025
Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose.

Guillermina Ferro-Flores, Erika Azorín-Vega, Blanca Ocampo-García

|Nov 27, 2024
Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study.

Sofía González-Rueda, Osvaldo García-Pérez, Myrna Luna-Gutiérrez

|Apr 27, 2024
68Ga-DOTA-D-Alanine-BoroPro Radiotracer for Imaging of the Fibroblast Activation Protein in Malignant and Non-Malignant Diseases.

Diana Trujillo-Benítez, Myrna Luna-Gutiérrez, José G Aguirre-De Paz

|Dec 23, 2023
99mTc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe.

Guillermina Ferro-Flores, Blanca Ocampo-García, Pedro Cruz-Nova

Pageof 3